LMY-920 for Treatment of Relapsed or Refractory Myeloma
Recruiting
Since CAR-T cell treatment of refractory myeloma has shown success, based on preclinical data, we posit that CAR-T cells expressing B-cell activating factor (BAFF) can become another strategy to treat refractory myeloma, even after relapse following BCMA targeting CAR-T cell treatment. This will be phase 1 study of BAFF ligand CAR-T cells in relapsed and refractory myeloma.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/16/2024
Locations: University Hospitals Seidman Cancer Center, Cleveland, Ohio
Conditions: Multiple Myeloma, Refractory, Multiple Myeloma in Relapse
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma
Recruiting
Therapy with chimeric antigen receptor T (CAR-T) cells has demonstrated activity against refractory lymphoma, however not all tumors respond or remain in response to CD19 targeted CAR-T cells. We posit that CAR-T cells expressing BAFF (BAFF CAR-T cells) can become another strategy to treat refractory lymphoma, even after relapse following cluster of differentiation antigen 19 (CD19) targeting CAR-T treatment. This phase 1 study will evaluate safe dose and provide initial signal of the activity... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/16/2024
Locations: University Hospitals Seidman Cancer Center, Cleveland, Ohio +1 locations
Conditions: Lymphoma, Non-Hodgkin Lymphoma, B-Cell
Corneal Elastography and Patient Specific Modeling
Recruiting
The goal of this research is to develop measurement tools and simulation technology for characterizing and predicting individual responses to corneal treatments and for advancing understanding of corneal ectasia risk factors. Patients who either 1) have keratoconus and are being evaluated for corneal crosslinking or 2) have refractive error and are being evaluated for refractive surgery procedures such as LASIK will have their eyes imaged to assess their mechanical properties and will have compu... Read More
Gender:
ALL
Ages:
Between 16 years and 80 years
Trial Updated:
10/11/2024
Locations: Cleveland Clinic Foundation Cole Eye Institute, Cleveland, Ohio
Conditions: Cornea; Ectasia, Refractive Errors, Keratoconus
Rebuilding Inter-limb Transfer in Cervical SCI
Recruiting
The purpose of this study in people living with cervical Spinal Cord Injury (SCI) is to examine the effects of paired neurostimulation (i.e., PCMS) combined with contralateral motor training on inter-limb transfer of ballistic motor and hand dexterity skills.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
10/11/2024
Locations: Lerner Research Institute; Cleveland Clinid Foundation, Cleveland, Ohio
Conditions: Cervical Spinal Cord Injury
Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients
Recruiting
The purpose of this study is to learn whether an education and support program can help caregivers feel more confident in technical and communication skills needed to care for a person with cancer. Patients with cancer and their caregivers face many challenges. These include learning about cancer and its treatment, coping with symptoms from illness and treatment side effects, making adjustments to usual activities, and managing the emotional effects of having a serious illness. This study is tes... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/09/2024
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio +1 locations
Conditions: Cancer
RASopathy Biorepository
Recruiting
The RASopathies are a group of developmental disorders caused by genetic changes in the genes that compose the Ras/mitogen activated protein kinase (MAPK) pathway. New RASopathies are being diagnosed frequently. This pathway is essential in the regulation of the cell cycle and the determination of cell function. Thus, appropriate function of this pathway is critical to normal development. Each syndrome in this group of disorders has unique phenotypic features, but there are many overlapping feat... Read More
Gender:
ALL
Ages:
All
Trial Updated:
10/08/2024
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Conditions: RAS Mutation, Neurofibromatosis 1, Noonan Syndrome, Noonan Syndrome With Multiple Lentigines, Noonan Neurofibromatosis Syndrome, Cardiofaciocutaneous Syndrome, Costello Syndrome, Legius Syndrome, Smith-Kingsmore Syndrome, SYNGAP1-Related Intellectual Disability, DLG4, MAPK1 Gene Mutation, MTOR Gene Mutation, GATOR-1 Gene Mutation
Family Navigation to Improve ADHD Treatment Adherence for Minority Children
Recruiting
ADHD is the most common pediatric neurodevelopmental disorder and is associated with significant long-term impairments. Current guidelines recommend stimulant medication and/or behavioral therapy as first-line treatments for ADHD. Despite evidence that consistent treatment is important for effectively managing ADHD symptoms, treatment adherence remains suboptimal and is especially problematic among minority children. Hypothesized reasons for racial/ethnic disparities in ADHD treatment include un... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/07/2024
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Conditions: Attention Deficit Hyperactivity Disorder
Oral Health Intervention in Adult Primary Care
Recruiting
This study is a Stage III cRCT to test the efficacy of multi-level interventions at the practice- and provider-level to address low dental utilization (attendance) among Medicaid-enrolled older adults 55 years or older attending non-urgent primary care visits (PCV) in MetroHealth practice settings. Twelve practices will be randomized into two arms: A) Intervention arm will receive the multi-level intervention that includes: 1. Practice-level: EHR changes to include: ask, advise, assess, and conn... Read More
Gender:
ALL
Ages:
55 years and above
Trial Updated:
10/04/2024
Locations: Case Western Reserve University, Cleveland, Ohio
Conditions: Dental Caries, Dry Mouth, Periodontal Diseases, Bleeding Gum
Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults with Bipolar Disorder
Recruiting
The purpose of this study is to use eye-tracking technology to study attentional biases, reward sensitivity, and cognitive control in adult patients with bipolar disorder with or without anxiety and/or substance use disorder comorbidity.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/04/2024
Locations: University Hospitals Cleveland Medical Center - Mood Disorders Program, Cleveland, Ohio
Conditions: Bipolar Disorder
Effect of Grapes in Inflammatory Bowel Disease
Recruiting
The overall objective of this pilot intervention study is to determine the impact of grape powder (46g/day freeze dried whole grape powder provided by the California Table Grape Commission) on the gut microbiotacomposition in adult patients with the IBD subtype Crohn's disease (CD).
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
10/04/2024
Locations: University Hospitals Cleveland Medical Center, Cleveland, Ohio
Conditions: Crohn Disease
TEAM-Red, a Remotely Delivered Self-management Program for Depressed Black Women at Risk for Hypertension
Recruiting
The proposed project is a 24-week prospective randomized controlled trial (RCT) evaluating the effects of TargEted MAnageMent Intervention (TEAM, N=41) vs. enhanced waitlist (eWL, N=41) control in young (\<50 years) African American women who are depressed or suffering from stress, and at risk for hypertension.
Gender:
FEMALE
Ages:
Between 18 years and 49 years
Trial Updated:
10/04/2024
Locations: University Hospitals Cleveland Medical Center, Cleveland, Ohio
Conditions: Depression
Aldosterone Renin Ratio (ARR) Test to Increase Case-detection of Primary Aldosteronism (PA)
Recruiting
The mission of this project is to increase the detection of Primary Aldosteronism (PA), the most common cause of secondary hypertension, which can either be cured surgically or treated with targeted medications.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
10/03/2024
Locations: The Cleveland Clinic Foundation, Cleveland, Ohio
Conditions: Primary Aldosteronism